Syndax Pharmaceuticals (SNDX) revenue breakdown
By product, Net product revenue is the largest at 72% of fiscal 2025 revenue, growing 1526% a year over 1 years.
Revenue by product
Fiscal years, as Syndax Pharmaceuticals reports them in its 10-K filings; fiscal 2025 total $172M.
| Products | 2024 | 2025 | Share |
|---|---|---|---|
| Net product revenue | $8M | $125M | 72% |
| Collaboration revenue | — | $42M | 25% |
| Milestone revenue | $16M | $5M | 3% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for SNDX.
Open SNDX in InvestinglyQuestions
Where does Syndax Pharmaceuticals make its money?
In fiscal 2025, by product: Net product revenue $125M, Collaboration revenue $42M, Milestone revenue $5M.
From Syndax Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.